Liver cancer risk check in type 2 diabetes patients
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study checks if people with type 2 diabetes and a higher score on a liver test (FIB-4) have a higher chance of liver cancer. You might get regular scans to find cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have type 2 diabetes and see your doctor regularly
- Your FIB-4 score is above 2.67 (based on recent blood tests)
- You are not currently getting liver ultrasound more than once a year
- You have not had liver cancer or other liver cancers in the past
- You are not pregnant or planning to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether offering an ultrasound and a blood test (alpha-fetoprotein) every 6 months can help find liver cancer early in people with cirrhosis (scarred liver) caused by conditions other than hepatitis B or C. The goal is to reduce deaths from liver cancer in this group.
This study tests a simple blood test (FIB-4) to check for liver scarring in people with type 2 diabetes. It may help find liver problems early so you can get the right care.
This study looks at your risk of developing liver cancer if you have hepatitis B. It uses your medical history and test results to give you a better idea of your risk and help guide next steps.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This study looks at whether adding a blood test (the GAAD score) to standard imaging can better detect liver cancer at an early stage in people with chronic liver disease. It may help you if you have cirrhosis or certain types of liver scarring.
This study tests whether adding a simple blood test (GAAD score) to a routine liver ultrasound can find early-stage liver cancer sooner in people with chronic liver conditions. It aims to improve detection in Asian populations at risk.
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.